Effects of Peanut Consumption on Postprandial Inflammation, Glucose and Triglycerides
NCT ID: NCT01173042
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
6 participants
INTERVENTIONAL
2009-08-31
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Peanut and Peanut Butter Consumption on Blood Lipids and Glycemic Control in Adults With Type 2 Diabetes
NCT00937222
Peanuts for Cardiometabolic, Brain, and Intestinal Health
NCT06867198
Eating Peanuts for Health
NCT01886326
The Effects of Consuming Palm Oil With Different Macronutrient Intakes on Blood Lipids
NCT02922062
Cardiometabolic Effects of Pecan Snacking in Prediabetes
NCT07235358
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Shake containing heavy whipping cream, glucose and chocolate syrup
Glucose and whipping cream
An oral liquid glucose (75g) and fat (high saturated fat from 60g heavy whipping cream) load. Chocolate syrup is added for flavor.
Peanut
Shake containing control (whipping cream, glucose and chocolate syrup) + 3oz of peanuts
Peanuts
Shake containing 3.0oz of peanuts (including skin) + control (heavy whipping cream, glucose and chocolate syrup)
Oil blend
Shake containing control (heavy whipping cream, glucose and chocolate syrup) + oil blend (equivalent to fatty acids provided in 3oz peanuts)
Oil Blend
Shake containing an oil blend (sunflower, sesame, olive and palm oils) + control (heavy whipping cream, glucose and chocolate syrup). The amount of oil added to the control will provide an equivalent amount of fat to that provided in 3 oz (85g) of peanuts
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peanuts
Shake containing 3.0oz of peanuts (including skin) + control (heavy whipping cream, glucose and chocolate syrup)
Glucose and whipping cream
An oral liquid glucose (75g) and fat (high saturated fat from 60g heavy whipping cream) load. Chocolate syrup is added for flavor.
Oil Blend
Shake containing an oil blend (sunflower, sesame, olive and palm oils) + control (heavy whipping cream, glucose and chocolate syrup). The amount of oil added to the control will provide an equivalent amount of fat to that provided in 3 oz (85g) of peanuts
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LDL\_C below 130 mg/dl
* TG below 350 mg/dl
* Blood pressure within normal ranges (below 140/90 mmHg)
Exclusion Criteria
* Allergies to peanuts or dairy products
* Known intolerance for high fat meals
* History of CVD, kidney disease, diabetes or inflammatory disease
* Use of non-steroidal anti-inflammatories or immunosuppressants
* Conditions requiring the use of steroids
* Use of medication or supplements for elevated lipids, blood pressure or glucose
30 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Peanut Institute
OTHER
Penn State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alison M Hill, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Penn State University, Department of Nutritiontal Sciences
Penny M. Kris-Etherton, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Penn State University, Department of Nutritional Sciences
Li Wang
Role: STUDY_DIRECTOR
Penn State University, Department of Nutritional Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Penn State University
University Park, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PKE105
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.